• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Peripartum cardiomyopathy: an intriguing challenge. Case report with literature review.

作者信息

Cemin Roberto, Janardhanan Rajesh, Daves Massimo

机构信息

Department of Cardiology, San Maurizio Regional Hospital, Bolzano, Italy.

出版信息

Curr Cardiol Rev. 2009 Nov;5(4):268-72. doi: 10.2174/157340309789317896.

DOI:10.2174/157340309789317896
PMID:21037843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2842958/
Abstract

Peripartum cardiomyopathy is a relatively rare disease, which can have devasting consequences and should be promptly identified and correctly treated. Overall prognosis is good in majority of the cases, although some patients may progress to irreversible heart failure. Early diagnosis is important and effective treatment reduces mortality rates and increases the chance of complete recovery of ventricular systolic function.We report of an interesting case with a favourable outcome and discuss about the clinical presentation, therapy and outcome of this condition.

摘要

相似文献

1
Peripartum cardiomyopathy: an intriguing challenge. Case report with literature review.
Curr Cardiol Rev. 2009 Nov;5(4):268-72. doi: 10.2174/157340309789317896.
2
Peripartum cardiomyopathy: moving towards a more central role of genetics.围产期心肌病:迈向遗传学的更核心作用
Curr Cardiol Rev. 2013 Aug;9(3):179-84. doi: 10.2174/1573403x113099990029.
3
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.围生期心肌病的病理生理学、诊断和治疗:欧洲心脏病学会心力衰竭协会围生期心肌病研究组的立场声明。
Eur J Heart Fail. 2019 Jul;21(7):827-843. doi: 10.1002/ejhf.1493. Epub 2019 Jun 27.
4
Peripartum Cardiomyopathy.围产期心肌病
J Educ Teach Emerg Med. 2023 Apr 30;8(2):S1-S34. doi: 10.21980/J8ZS9M. eCollection 2023 Apr.
5
Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes.围产期心肌病发病时的右心室功能与随后的左心室恢复及临床结局相关。
Circ Heart Fail. 2016 May;9(5). doi: 10.1161/CIRCHEARTFAILURE.115.002756.
6
Intravenous immune globulin in the therapy of peripartum cardiomyopathy.静脉注射免疫球蛋白在围产期心肌病治疗中的应用
J Am Coll Cardiol. 1999 Jul;34(1):177-80. doi: 10.1016/s0735-1097(99)00161-8.
7
[Peripartum cardiomyopathy--a case report].[围产期心肌病——一例报告]
Wiad Lek. 2015;68(1):99-103.
8
Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.围生期心肌病并发心原性休克:早期左心室减压和溴隐亭治疗的重要性。
Eur Heart J Acute Cardiovasc Care. 2020 Mar;9(2):173-182. doi: 10.1177/2048872618777876. Epub 2018 May 24.
9
Peripartum cardiomyopathy: A review.围产期心肌病:综述
Rev Port Cardiol. 2023 Nov;42(11):917-924. doi: 10.1016/j.repc.2023.01.029. Epub 2023 Jul 4.
10
Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports.溴隐亭治疗与同胞姐妹围产期心肌病康复相关:两例病例报告。
J Med Case Rep. 2010 Mar 4;4:80. doi: 10.1186/1752-1947-4-80.

引用本文的文献

1
Peripartum cardiomyopathy: moving towards a more central role of genetics.围产期心肌病:迈向遗传学的更核心作用
Curr Cardiol Rev. 2013 Aug;9(3):179-84. doi: 10.2174/1573403x113099990029.

本文引用的文献

1
The role of MRI in peripartum cardiomyopathy.MRI 在围生期心肌病中的作用。
Int J Cardiol. 2009 Oct 2;137(2):185-6. doi: 10.1016/j.ijcard.2008.05.063. Epub 2008 Aug 6.
2
Incidence, mortality, and racial differences in peripartum cardiomyopathy.围产期心肌病的发病率、死亡率及种族差异。
Am J Cardiol. 2007 Jul 15;100(2):302-4. doi: 10.1016/j.amjcard.2007.02.092. Epub 2007 Jun 6.
3
Extracorporeal membrane oxygenation in a patient with peripartum cardiomyopathy.围产期心肌病患者的体外膜肺氧合治疗
Ann Thorac Surg. 2007 Jul;84(1):262-4. doi: 10.1016/j.athoracsur.2007.02.050.
4
Peripartum cardiomyopathy: a comprehensive review.围产期心肌病:综述
Int J Cardiol. 2007 Jun 12;118(3):295-303. doi: 10.1016/j.ijcard.2006.08.005. Epub 2007 Jan 17.
5
Peripartum cardiomyopathy.围产期心肌病
Int J Gynaecol Obstet. 2006 Nov;95(2):104-9. doi: 10.1016/j.ijgo.2006.06.013. Epub 2006 Aug 28.
6
Improved outcomes in peripartum cardiomyopathy with contemporary.当代围产期心肌病的预后改善。
Am Heart J. 2006 Sep;152(3):509-13. doi: 10.1016/j.ahj.2006.02.008.
7
Peripartum cardiomyopathy.围产期心肌病
Lancet. 2006 Aug 19;368(9536):687-93. doi: 10.1016/S0140-6736(06)69253-2.
8
Peripartum cardiomyopathy.围产期心肌病
Minerva Cardioangiol. 2006 Jun;54(3):331-6.
9
Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution.在单一机构对围产期心肌病的发病率和预后进行的五年前瞻性研究。
Mayo Clin Proc. 2005 Dec;80(12):1602-6. doi: 10.4065/80.12.1602.
10
Viral persistence in the myocardium is associated with progressive cardiac dysfunction.病毒在心肌中的持续存在与进行性心脏功能障碍有关。
Circulation. 2005 Sep 27;112(13):1965-70. doi: 10.1161/CIRCULATIONAHA.105.548156. Epub 2005 Sep 19.